Xilin Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xilin Zhao has a total of 244 co-authors. Here are the top co-authors by number of shared publications:
Karl Drlica
Public Health Research Institute and Department of Microbiology, Biochemistry & Molecular Genetics, New Jersey Medical School Rutgers University Newark New Jersey USA
32 shared publicationsMuhammad Malik
Public Heath Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Science, 225 Warren Street, Newark, NJ 07103, USA
13 shared publications- Karl Drlica
Public Health Research Institute, New York, New York 10016,1 and Parke-Davis Pharmaceutical Research Division, Warner Lambert Company, Ann Arbor, Michigan 481052
11 shared publications Yuzhi Hong
Minister of Education Key Laboratory of Geriatric Diseases and Immunology, Suzhou Key Laboratory of Pathogen Bioscience and Anti-infective Medicine, Institute of Molecular Enzymology, School of Biology and Basic Medical Sciences, Soochow University
10 shared publications- Karl Drlica
Public Health Research Institute, 225 Warren Street, Newark, New Jersey 07103
9 shared publications Tao Lu
Public Health Research Institute Center, New Jersey Medical School, UMDNJ. 225 Warren St, Newark, NJ 07103
9 shared publications
Latest Publications
- Open Access
Quinolone tolerance in Escherichia coli due to defects in the adenosine ribonucleotides de novo biosynthesis pathway
Central carbon metabolism is thought to link reactive oxygen species (ROS) with antibiotic‐mediated bacterial death. During enrichment screening of Escherichia coli with the first‐generation quinolone oxolinic acid, unstable antibiotic‐tolerant mutants containing deficiencies in purB were obtained. Examination of a stable deletion mutant of purA , a gene functionally related to purB , revealed reduced lethality of oxolinic acid and ciprofloxacin. This deletion mutation had little effect on the minimal inhibitory concentration (MIC) of quinolones, thereby demonstrating that the observed protection from killing was attributable to antibiotic tolerance. AMP synthesis was blocked by the Δ purA mutation, and ciprofloxacin tolerance was reversed by exogenous AMP supplementation. Because AMP is a precursor of ATP, interference with ATP synthesis occurs in the Δ purA mutant. RNA‐Seq analysis showed that, prior to antibiotic stress, transcript levels of NADH:quinone oxidoreductase genes were reduced by the purA deficiency, thereby predisposing E. coli to antibiotic tolerance through reduced respiration. During ciprofloxacin exposure, the purA deficiency also suppressed the surge in expression of tricarboxylic acid (TCA) cycle and ATP synthesis genes, as well as the accumulation of intracellular ATP and ROS. Thus, wild‐type PurA, and by extension the downstream enzyme PurB, directs AMP toward an antibiotic‐mediated, ROS‐dependent death pathway. Overall, defects in PurA/PurB‐mediated adenosine ribonucleotides de novo biosynthesis reveal a novel quinolone tolerance mechanism that is initiated outside central carbon metabolism; tolerance is likely attributable to a limited supply of AMP, resulting in reduced ATP synthesis and suppression of ROS accumulation.
Open AccessQuinolone tolerance in Escherichia coli due to defects in the adenosine ribonucleotides de novo biosynthesis pathway
Central carbon metabolism is thought to link reactive oxygen species (ROS) with antibiotic‐mediated bacterial death. During enrichment screening of Escherichia coli with the first‐generation quinolone oxolinic acid, unstable antibiotic‐tolerant mutants containing deficiencies in purB were obtained. Examination of a stable deletion mutant of purA , a gene functionally related to purB , revealed reduced lethality of oxolinic acid and ciprofloxacin. This deletion mutation had little effect on the minimal inhibitory concentration (MIC) of quinolones, thereby demonstrating that the observed protection from killing was attributable to antibiotic tolerance. AMP synthesis was blocked by the Δ purA mutation, and ciprofloxacin tolerance was reversed by exogenous AMP supplementation. Because AMP is a precursor of ATP, interference with ATP synthesis occurs in the Δ purA mutant. RNA‐Seq analysis showed that, prior to antibiotic stress, transcript levels of NADH:quinone oxidoreductase genes were reduced by the purA deficiency, thereby predisposing E. coli to antibiotic tolerance through reduced respiration. During ciprofloxacin exposure, the purA deficiency also suppressed the surge in expression of tricarboxylic acid (TCA) cycle and ATP synthesis genes, as well as the accumulation of intracellular ATP and ROS. Thus, wild‐type PurA, and by extension the downstream enzyme PurB, directs AMP toward an antibiotic‐mediated, ROS‐dependent death pathway. Overall, defects in PurA/PurB‐mediated adenosine ribonucleotides de novo biosynthesis reveal a novel quinolone tolerance mechanism that is initiated outside central carbon metabolism; tolerance is likely attributable to a limited supply of AMP, resulting in reduced ATP synthesis and suppression of ROS accumulation.
- Open Access
- 13 August 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (8) , e0119925
Antibiotic-persistent bacterial cells exhibiting low-level ROS are eradicated by ROS-independent membrane disruption
Bacterial persistence increases therapy duration, disease relapse, and antibiotic resistance. Mechanisms underlying persistence and feasible ways to rapidly eliminate persister cells are largely unknown. The present work examined genetic and environmental perturbations to identify anti-death events occurring in Escherichia coli persister and phenotypically tolerant cells. The quiescent status of hipA7 and metG2 persister cells, which were protected from killing by multiple antibiotics, was insensitive to the presence/absence of exogenous nutrients. In contrast, stationary-phase and nutrient-starved wild-type cultures, which displayed tolerance rather than the subpopulation status of persistence, were readily killed by ciprofloxacin upon restoration of nutrients, thereby indicating that tolerance was phenotypic. Both persistent and tolerant cells suppressed accumulation of reactive oxygen species (ROS), DNA breakage, and global metabolic activity. Restoration of nutrients to stationary-phase cultures restored these three processes for phenotypically tolerant cells but not for persister cells. Cultures of high-frequency-persistent hipA7 and metG2 mutants and low-frequency-persistent wild-type cells were rapidly sterilized by ROS-independent, synergistic membrane disruption using aminoglycoside-polymyxin combinations; rapid eradication occurred at clinically achievable concentrations for both antibiotics. The aminoglycoside-polymyxin combination also killed environmentally tolerant cells but more slowly. The combination killed both laboratory and clinical isolates of gram-negative bacteria, an E. coli ptsI mutant that is pan-tolerant to diverse antibiotics and disinfectants, and E. coli cells in a biofilm model. Moderate lethality was observed with the gram-positive bacterium Staphylococcus aureus . The work indicates that suppression of ROS accumulation is a common feature of persistence and phenotypic tolerance, and it emphasizes ROS-independent strategies for controlling quiescent bacterial populations. IMPORTANCE: The report generalizes the concept that persistence and tolerance involve suppression of toxic metabolites (reactive oxygen species [ROS]). The work also shows that an environmental perturbation (nutrient deprivation) leads to antibiotic tolerance rather than persistence, thereby raising questions about the classification of other environmental perturbations. The synergistic action of multiple aminoglycoside species with polymyxins opens many treatment options. Lethality with biofilms and with S. aureus may extend polymyxin-based therapies beyond planktonic, gram-negative bacteria, and the ROS independence of the combination may allow antioxidant mitigation of drug toxicity. Overall, the work advances our knowledge of persistent and tolerant bacterial pathogens and our efforts to eradicate them.
- 13 August 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (8) , e0119925
Open AccessAntibiotic-persistent bacterial cells exhibiting low-level ROS are eradicated by ROS-independent membrane disruption
Bacterial persistence increases therapy duration, disease relapse, and antibiotic resistance. Mechanisms underlying persistence and feasible ways to rapidly eliminate persister cells are largely unknown. The present work examined genetic and environmental perturbations to identify anti-death events occurring in Escherichia coli persister and phenotypically tolerant cells. The quiescent status of hipA7 and metG2 persister cells, which were protected from killing by multiple antibiotics, was insensitive to the presence/absence of exogenous nutrients. In contrast, stationary-phase and nutrient-starved wild-type cultures, which displayed tolerance rather than the subpopulation status of persistence, were readily killed by ciprofloxacin upon restoration of nutrients, thereby indicating that tolerance was phenotypic. Both persistent and tolerant cells suppressed accumulation of reactive oxygen species (ROS), DNA breakage, and global metabolic activity. Restoration of nutrients to stationary-phase cultures restored these three processes for phenotypically tolerant cells but not for persister cells. Cultures of high-frequency-persistent hipA7 and metG2 mutants and low-frequency-persistent wild-type cells were rapidly sterilized by ROS-independent, synergistic membrane disruption using aminoglycoside-polymyxin combinations; rapid eradication occurred at clinically achievable concentrations for both antibiotics. The aminoglycoside-polymyxin combination also killed environmentally tolerant cells but more slowly. The combination killed both laboratory and clinical isolates of gram-negative bacteria, an E. coli ptsI mutant that is pan-tolerant to diverse antibiotics and disinfectants, and E. coli cells in a biofilm model. Moderate lethality was observed with the gram-positive bacterium Staphylococcus aureus . The work indicates that suppression of ROS accumulation is a common feature of persistence and phenotypic tolerance, and it emphasizes ROS-independent strategies for controlling quiescent bacterial populations. IMPORTANCE: The report generalizes the concept that persistence and tolerance involve suppression of toxic metabolites (reactive oxygen species [ROS]). The work also shows that an environmental perturbation (nutrient deprivation) leads to antibiotic tolerance rather than persistence, thereby raising questions about the classification of other environmental perturbations. The synergistic action of multiple aminoglycoside species with polymyxins opens many treatment options. Lethality with biofilms and with S. aureus may extend polymyxin-based therapies beyond planktonic, gram-negative bacteria, and the ROS independence of the combination may allow antioxidant mitigation of drug toxicity. Overall, the work advances our knowledge of persistent and tolerant bacterial pathogens and our efforts to eradicate them.
- Open Access
- 1 July 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (7) , e0339824
Evolution and characteristics of tetracycline resistance in Mycoplasma pneumoniae
Macrolide resistance in Mycoplasma pneumoniae is becoming prevalent. Tetracyclines are an important alternative for patients with macrolide-resistant M. pneumoniae infections. Tetracycline-resistant M. pneumoniae has never been reported in clinical isolates or in vitro -induced strains. Here, we aimed to explore tetracycline-resistant M. pneumoniae in vitro and the underlying resistance mechanisms. Clinically isolated parental M. pneumoniae strains were selected for tetracycline resistance by inducing them in vitro with increasing concentrations of tetracycline, minocycline, and tigecycline. The whole genomes of the induced resistant and parent strains were both sequenced to identify tetracycline-resistance genes, and their 16S rRNA gene sequences were compared. Ribosome-binding assays were conducted by incubating the 30S ribosomes of the resistant and sensitive strains with various concentrations of 3 H-labeled tetracycline. The effect of efflux pump inhibitor reserpine on the susceptibility of tetracyclines to the resistant mutants was evaluated. Eight resistant mutants were obtained from 12 tetracycline-susceptible M. pneumoniae strains. Whole-genome sequencing identified point mutations in the 16S rRNA gene of all the resistant mutants. The ribosomes of two induced resistant strains showed lower tetracycline-binding capacities than their parental strains. Reserpine increased the susceptibility of two resistant mutants to tetracyclines by more than fourfold. None of the resistant mutants carried the known tetracycline-resistance genes. M. pneumoniae strains can develop tetracycline resistance. Mutations in the 16S rRNA gene leading to decreased ribosomal-binding capacity and the presence of efflux pumps may be the mechanisms associated with tetracycline resistance in M. pneumoniae . This study identifies markers to track the emergence of tetracycline resistance in M. pneumoniae . IMPORTANCE: Resistance to anti- Mycoplasma pneumoniae antibiotics is a global public health problem. Effective antibiotic treatment strategies are urgently needed. Tetracyclines are among the most commonly used antibiotics for the treatment of drug-resistant M. pneumoniae infections. Tetracycline-resistant M. pneumoniae has not been reported; however, treatment with increased concentrations of tetracycline selects hyposensitive mutants. In this study, we successfully induced tetracycline-resistant M. pneumoniae mutants by 10-month in vitro serial passage experiments and found that a 16S rRNA mutation resulting in reduced ribosomal drug binding was the mechanism that led to tetracycline resistance in M. pneumoniae . In addition, the efflux pump might also be related to decreased tetracycline susceptibility. This study presented the first data on the induction of tetracycline resistance in M. pneumoniae in vitro , providing insights into the development of effective treatment strategies for drug-resistant M. pneumoniae infections in the future.
- 1 July 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (7) , e0339824
Open AccessEvolution and characteristics of tetracycline resistance in Mycoplasma pneumoniae
Macrolide resistance in Mycoplasma pneumoniae is becoming prevalent. Tetracyclines are an important alternative for patients with macrolide-resistant M. pneumoniae infections. Tetracycline-resistant M. pneumoniae has never been reported in clinical isolates or in vitro -induced strains. Here, we aimed to explore tetracycline-resistant M. pneumoniae in vitro and the underlying resistance mechanisms. Clinically isolated parental M. pneumoniae strains were selected for tetracycline resistance by inducing them in vitro with increasing concentrations of tetracycline, minocycline, and tigecycline. The whole genomes of the induced resistant and parent strains were both sequenced to identify tetracycline-resistance genes, and their 16S rRNA gene sequences were compared. Ribosome-binding assays were conducted by incubating the 30S ribosomes of the resistant and sensitive strains with various concentrations of 3 H-labeled tetracycline. The effect of efflux pump inhibitor reserpine on the susceptibility of tetracyclines to the resistant mutants was evaluated. Eight resistant mutants were obtained from 12 tetracycline-susceptible M. pneumoniae strains. Whole-genome sequencing identified point mutations in the 16S rRNA gene of all the resistant mutants. The ribosomes of two induced resistant strains showed lower tetracycline-binding capacities than their parental strains. Reserpine increased the susceptibility of two resistant mutants to tetracyclines by more than fourfold. None of the resistant mutants carried the known tetracycline-resistance genes. M. pneumoniae strains can develop tetracycline resistance. Mutations in the 16S rRNA gene leading to decreased ribosomal-binding capacity and the presence of efflux pumps may be the mechanisms associated with tetracycline resistance in M. pneumoniae . This study identifies markers to track the emergence of tetracycline resistance in M. pneumoniae . IMPORTANCE: Resistance to anti- Mycoplasma pneumoniae antibiotics is a global public health problem. Effective antibiotic treatment strategies are urgently needed. Tetracyclines are among the most commonly used antibiotics for the treatment of drug-resistant M. pneumoniae infections. Tetracycline-resistant M. pneumoniae has not been reported; however, treatment with increased concentrations of tetracycline selects hyposensitive mutants. In this study, we successfully induced tetracycline-resistant M. pneumoniae mutants by 10-month in vitro serial passage experiments and found that a 16S rRNA mutation resulting in reduced ribosomal drug binding was the mechanism that led to tetracycline resistance in M. pneumoniae . In addition, the efflux pump might also be related to decreased tetracycline susceptibility. This study presented the first data on the induction of tetracycline resistance in M. pneumoniae in vitro , providing insights into the development of effective treatment strategies for drug-resistant M. pneumoniae infections in the future.
- Open Access
- 3 February 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (6)
Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetase
Disinfectants are essential tools for controlling infectious diseases and maintaining sterile conditions in many medical and food-industry settings. Recent work revealed that a deficiency in the carbohydrate phosphotransferase system (PTS) confers pan-tolerance to killing by diverse disinfectant types through its interaction with the cAMP-CRP regulatory network. The present work characterized a pan-tolerance mutant obtained by enrichment using phenol as a lethal probe and an Escherichia coli PTS null mutant as a parental strain. The resulting super-pan-tolerant mutant, which harbored an F158C substitution in PheS, inhibited bacterial killing by multiple disinfectant classes with surprisingly little effect on antimicrobial lethality. The PheS substitution, which was expected to lower substrate recognition efficiency and result in deacylated tRNA phe occupying the ribosomal A site, activated relA expression and synthesis of ppGpp, even in the absence of disinfectant exposure. ppGpp, along with DksA, increased RpoS function by activating promoters of dsrA and iraP , two genes whose products increase the expression and stability of RpoS. Subsequently, RpoS upregulated the expression of genes encoding a universal stress protein (UspB) and an oxidative stress peroxidase (KatE), which preconditioned bacteria to better survive a variety of disinfectants. Disinfectant-mediated accumulation of reactive oxygen species (ROS) and bacterial killing were abolished/reduced by exogenous dimethyl sulfoxide and by a PheS F158C substitution up-regulating genes encoding ROS-detoxifying enzymes ( katE, sodA, oxyR, ahpC ). These data identify a pheS mutation-triggered, ppGpp-stimulated transcriptional regulatory cascade that negates biocide-mediated lethality, thereby tying the stringent response to protection from ROS-mediated biocide lethality.
- 3 February 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (6)
Open AccessBroad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetase
Disinfectants are essential tools for controlling infectious diseases and maintaining sterile conditions in many medical and food-industry settings. Recent work revealed that a deficiency in the carbohydrate phosphotransferase system (PTS) confers pan-tolerance to killing by diverse disinfectant types through its interaction with the cAMP-CRP regulatory network. The present work characterized a pan-tolerance mutant obtained by enrichment using phenol as a lethal probe and an Escherichia coli PTS null mutant as a parental strain. The resulting super-pan-tolerant mutant, which harbored an F158C substitution in PheS, inhibited bacterial killing by multiple disinfectant classes with surprisingly little effect on antimicrobial lethality. The PheS substitution, which was expected to lower substrate recognition efficiency and result in deacylated tRNA phe occupying the ribosomal A site, activated relA expression and synthesis of ppGpp, even in the absence of disinfectant exposure. ppGpp, along with DksA, increased RpoS function by activating promoters of dsrA and iraP , two genes whose products increase the expression and stability of RpoS. Subsequently, RpoS upregulated the expression of genes encoding a universal stress protein (UspB) and an oxidative stress peroxidase (KatE), which preconditioned bacteria to better survive a variety of disinfectants. Disinfectant-mediated accumulation of reactive oxygen species (ROS) and bacterial killing were abolished/reduced by exogenous dimethyl sulfoxide and by a PheS F158C substitution up-regulating genes encoding ROS-detoxifying enzymes ( katE, sodA, oxyR, ahpC ). These data identify a pheS mutation-triggered, ppGpp-stimulated transcriptional regulatory cascade that negates biocide-mediated lethality, thereby tying the stringent response to protection from ROS-mediated biocide lethality.
- Open Access
- 19 December 2024
- Published by American Society for Microbiology in mSphere
- Vol. 9 (12) , e0077224
Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Enzyme-IIA (EIIA Glc , Crr) of the phosphotransferase system (PTS) connects the uptake of glucose-family sugars to the cAMP-Crp regulatory cascade; phosphorylated EIIA Glc enhances cAMP-Crp activity, which then contributes to the antibiotic-mediated accumulation of reactive oxygen species (ROS) and cell death. Defects in PTS cause antibiotic and disinfectant tolerance. We report that mannitol, a carbon source whose uptake does not use EIIA Glc , reduces antibiotic-mediated killing of Escherichia coli without affecting antibiotic minimal inhibitory concentration. Thus, mannitol promotes antibiotic tolerance. The tolerance pathway was defined by the loss of ciprofloxacin lethality from the deletion of ptsI (first gene in PTS), mtlA (mannitol-specific Enzyme-II), cyaA (cAMP synthase), and crp (cAMP receptor protein) but not crr (EIIA Glc ). A crp* mutant, which encodes a constitutively active Crp that bypasses the need for cAMP activation, also decreased mannitol-mediated antibiotic tolerance, as did exogenous cAMP. Thus, inhibition of antibiotic lethality by mannitol involves both PTS-mediated mannitol uptake and suppression of cAMP-Crp action, independent of EIIA Glc . Mannitol suppressed the downstream antibiotic-mediated transcription of genes involved in NADH production and cellular respiration, expression of a superoxide reporter gene ( soxS ), and accumulation of antibiotic-mediated ROS. Similar phenomena were observed with mannose and sorbitol, demonstrating that non-glucose PTS carbon sources can cause antibiotic tolerance by a novel path that reduces the ROS-promoting activity of cAMP-Crp. The work emphasizes that antibiotic tolerance, which contributes to disease relapse and the need for prolonged antibiotic treatment, can result from commonly consumed carbohydrates. This finding, plus mutations that interfere specifically with antibiotic lethality, makes tolerance a high probability event. IMPORTANCE: Bacterial tolerance constitutes a significant threat to anti-infective therapy and potentially to the use of disinfectants. Deficiency mutations that reduce glucose uptake, central carbon metabolism, and cellular respiration confer antibiotic/disinfectant tolerance by reducing the accumulation of reactive metabolites, such as reactive oxygen species. We identified novel environmental generators of tolerance by showing that non-glucose carbohydrates, such as mannitol, mannose, and sorbitol, generate tolerance to multiple antibiotic classes. Finding that these sugars inhibit a universal, stress-mediated death pathway emphasizes the potential danger of compounds that block the lethal response to severe stress. Immediate practical importance derives from mannitol being a popular food sweetener, a treatment for glaucoma, and a dehydrating agent for treating cerebral edema, including cases caused by bacterial infection: antibiotic tolerance could contra-indicate the use of mannitol and related carbohydrates during antibiotic treatment. Overall, the work shows that the presence of sugars must be considered during antimicrobial and perhaps disinfectant use.
- 19 December 2024
- Published by American Society for Microbiology in mSphere
- Vol. 9 (12) , e0077224
Open AccessAntibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Enzyme-IIA (EIIA Glc , Crr) of the phosphotransferase system (PTS) connects the uptake of glucose-family sugars to the cAMP-Crp regulatory cascade; phosphorylated EIIA Glc enhances cAMP-Crp activity, which then contributes to the antibiotic-mediated accumulation of reactive oxygen species (ROS) and cell death. Defects in PTS cause antibiotic and disinfectant tolerance. We report that mannitol, a carbon source whose uptake does not use EIIA Glc , reduces antibiotic-mediated killing of Escherichia coli without affecting antibiotic minimal inhibitory concentration. Thus, mannitol promotes antibiotic tolerance. The tolerance pathway was defined by the loss of ciprofloxacin lethality from the deletion of ptsI (first gene in PTS), mtlA (mannitol-specific Enzyme-II), cyaA (cAMP synthase), and crp (cAMP receptor protein) but not crr (EIIA Glc ). A crp* mutant, which encodes a constitutively active Crp that bypasses the need for cAMP activation, also decreased mannitol-mediated antibiotic tolerance, as did exogenous cAMP. Thus, inhibition of antibiotic lethality by mannitol involves both PTS-mediated mannitol uptake and suppression of cAMP-Crp action, independent of EIIA Glc . Mannitol suppressed the downstream antibiotic-mediated transcription of genes involved in NADH production and cellular respiration, expression of a superoxide reporter gene ( soxS ), and accumulation of antibiotic-mediated ROS. Similar phenomena were observed with mannose and sorbitol, demonstrating that non-glucose PTS carbon sources can cause antibiotic tolerance by a novel path that reduces the ROS-promoting activity of cAMP-Crp. The work emphasizes that antibiotic tolerance, which contributes to disease relapse and the need for prolonged antibiotic treatment, can result from commonly consumed carbohydrates. This finding, plus mutations that interfere specifically with antibiotic lethality, makes tolerance a high probability event. IMPORTANCE: Bacterial tolerance constitutes a significant threat to anti-infective therapy and potentially to the use of disinfectants. Deficiency mutations that reduce glucose uptake, central carbon metabolism, and cellular respiration confer antibiotic/disinfectant tolerance by reducing the accumulation of reactive metabolites, such as reactive oxygen species. We identified novel environmental generators of tolerance by showing that non-glucose carbohydrates, such as mannitol, mannose, and sorbitol, generate tolerance to multiple antibiotic classes. Finding that these sugars inhibit a universal, stress-mediated death pathway emphasizes the potential danger of compounds that block the lethal response to severe stress. Immediate practical importance derives from mannitol being a popular food sweetener, a treatment for glaucoma, and a dehydrating agent for treating cerebral edema, including cases caused by bacterial infection: antibiotic tolerance could contra-indicate the use of mannitol and related carbohydrates during antibiotic treatment. Overall, the work shows that the presence of sugars must be considered during antimicrobial and perhaps disinfectant use.
- Open Access
- 17 August 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (4) , e0119823
Enhancement of β-Lactam-Mediated Killing of Gram-Negative Bacteria by Lysine Hydrochloride
Antibiotic resistance among Gram-negative pathogens is a serious medical problem. The present work describes a new study in which a nontoxic nutrient increases the lethal action of clinically important β-lactams.
- 17 August 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (4) , e0119823
Open AccessEnhancement of β-Lactam-Mediated Killing of Gram-Negative Bacteria by Lysine Hydrochloride
Antibiotic resistance among Gram-negative pathogens is a serious medical problem. The present work describes a new study in which a nontoxic nutrient increases the lethal action of clinically important β-lactams.
- Open Access
- 26 May 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1174510
Interplays of mutations in waaA, cmk, and ail contribute to phage resistance in Yersinia pestis
Plague caused by Yersinia pestis remains a public health threat worldwide. Because multidrug-resistant Y. pestis strains have been found in both humans and animals, phage therapy has attracted increasing attention as an alternative strategy against plague. However, phage resistance is a potential drawback of phage therapies, and the mechanism of phage resistance in Y. pestis is yet to be investigated. In this study, we obtained a bacteriophage-resistant strain of Y. pestis (S56) by continuously challenging Y. pestis 614F with the bacteriophage Yep-phi. Genome analysis identified three mutations in strain S56: waaA* (9-bp in-frame deletion 249GTCATCGTG257), cmk* (10-bp frameshift deletion 15CCGGTGATAA24), and ail* (1-bp frameshift deletion A538). WaaA (3-deoxy-D-manno-octulosonic acid transferase) is a key enzyme in lipopolysaccharide biosynthesis. The waaA* mutation leads to decreased phage adsorption because of the failure to synthesize the lipopolysaccharide core. The mutation in cmk (encoding cytidine monophosphate kinase) increased phage resistance, independent of phage adsorption, and caused in vitro growth defects in Y. pestis. The mutation in ail inhibited phage adsorption while restoring the growth of the waaA null mutant and accelerating the growth of the cmk null mutant. Our results confirmed that mutations in the WaaA–Cmk–Ail cascade in Y. pestis contribute to resistance against bacteriophage. Our findings help in understanding the interactions between Y. pestis and its phages.
- 26 May 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1174510
Open AccessInterplays of mutations in waaA, cmk, and ail contribute to phage resistance in Yersinia pestis
Plague caused by Yersinia pestis remains a public health threat worldwide. Because multidrug-resistant Y. pestis strains have been found in both humans and animals, phage therapy has attracted increasing attention as an alternative strategy against plague. However, phage resistance is a potential drawback of phage therapies, and the mechanism of phage resistance in Y. pestis is yet to be investigated. In this study, we obtained a bacteriophage-resistant strain of Y. pestis (S56) by continuously challenging Y. pestis 614F with the bacteriophage Yep-phi. Genome analysis identified three mutations in strain S56: waaA* (9-bp in-frame deletion 249GTCATCGTG257), cmk* (10-bp frameshift deletion 15CCGGTGATAA24), and ail* (1-bp frameshift deletion A538). WaaA (3-deoxy-D-manno-octulosonic acid transferase) is a key enzyme in lipopolysaccharide biosynthesis. The waaA* mutation leads to decreased phage adsorption because of the failure to synthesize the lipopolysaccharide core. The mutation in cmk (encoding cytidine monophosphate kinase) increased phage resistance, independent of phage adsorption, and caused in vitro growth defects in Y. pestis. The mutation in ail inhibited phage adsorption while restoring the growth of the waaA null mutant and accelerating the growth of the cmk null mutant. Our results confirmed that mutations in the WaaA–Cmk–Ail cascade in Y. pestis contribute to resistance against bacteriophage. Our findings help in understanding the interactions between Y. pestis and its phages.
- Open Access
- 14 February 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (1) , e0379022
Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens
As antimicrobial resistance continues to increase, options for effectively treating multidrug-resistant (MDR) Gram-negative infections are declining. Finding ways to enhance the lethality of old agents that have unique molecular targets is important because developing new antimicrobials is becoming increasingly difficult.
- 14 February 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (1) , e0379022
Open AccessBicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens
As antimicrobial resistance continues to increase, options for effectively treating multidrug-resistant (MDR) Gram-negative infections are declining. Finding ways to enhance the lethality of old agents that have unique molecular targets is important because developing new antimicrobials is becoming increasingly difficult.
- Open Access
- 20 December 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 1055929
Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms
Multidrug-resistant (MDR) bacteria pose a significant clinical threat to human health, but the development of antibiotics cannot meet the urgent need for effective agents, especially those that can kill persisters and biofilms. Here, we reported that nigericin showed potent bactericidal activity against various clinical MDR Gram-positive bacteria, persisters and biofilms, with low frequencies of resistance development. Moreover, nigericin exhibited favorable in vivo efficacy in deep-seated mouse biofilm, murine skin and bloodstream infection models. With Staphylococcus aureus, nigericin disrupted ATP production and electron transport chain; cell death was associated with altered membrane structure and permeability. Obtaining nigericin-resistant/tolerant mutants required multiple rounds of challenge, and, cross-resistance to members of several antimicrobial classes was absent, probably due to distinct nigericin action with the GraSR two-component regulatory system. Thus, our work reveals that nigericin is a promising antibiotic candidate for the treatment of chronic or recurrent infections caused by Gram-positive bacteria.
- 20 December 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 1055929
Open AccessNigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms
Multidrug-resistant (MDR) bacteria pose a significant clinical threat to human health, but the development of antibiotics cannot meet the urgent need for effective agents, especially those that can kill persisters and biofilms. Here, we reported that nigericin showed potent bactericidal activity against various clinical MDR Gram-positive bacteria, persisters and biofilms, with low frequencies of resistance development. Moreover, nigericin exhibited favorable in vivo efficacy in deep-seated mouse biofilm, murine skin and bloodstream infection models. With Staphylococcus aureus, nigericin disrupted ATP production and electron transport chain; cell death was associated with altered membrane structure and permeability. Obtaining nigericin-resistant/tolerant mutants required multiple rounds of challenge, and, cross-resistance to members of several antimicrobial classes was absent, probably due to distinct nigericin action with the GraSR two-component regulatory system. Thus, our work reveals that nigericin is a promising antibiotic candidate for the treatment of chronic or recurrent infections caused by Gram-positive bacteria.
- Open Access
- 1 June 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (23)
A broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascade
Significance: Finding that pan-tolerance derives from defects in carbohydrate regulation connects stress-mediated lesions with metabolic change, identifies a stable type of tolerance, and demonstrates a widely shared death response. Manipulation of the response should improve antimicrobial efficacy, preserve beneficial bacteria during antimicrobial use, and protect industrial bacteria from toxic products. Mutations in many genes can interfere with stress-mediated metabolism; thus, mutation to pan-tolerance could be a high-probability event. Finding that selection of tolerance to one lethal stressor confers tolerance to many, if not all, indicates that massive disinfectant consumption potentially undermines antimicrobial efficacy and immune defenses against pathogenic bacteria. Since pan-tolerance is hidden from current surveillance of resistance, the work indicates a need for facile methods to measure tolerance.
- 1 June 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (23)
Open AccessA broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascade
Significance: Finding that pan-tolerance derives from defects in carbohydrate regulation connects stress-mediated lesions with metabolic change, identifies a stable type of tolerance, and demonstrates a widely shared death response. Manipulation of the response should improve antimicrobial efficacy, preserve beneficial bacteria during antimicrobial use, and protect industrial bacteria from toxic products. Mutations in many genes can interfere with stress-mediated metabolism; thus, mutation to pan-tolerance could be a high-probability event. Finding that selection of tolerance to one lethal stressor confers tolerance to many, if not all, indicates that massive disinfectant consumption potentially undermines antimicrobial efficacy and immune defenses against pathogenic bacteria. Since pan-tolerance is hidden from current surveillance of resistance, the work indicates a need for facile methods to measure tolerance.